Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy.

Chi-Juei JengYi-Ting HsiehCheng-Li LinI-Jong Wang

Published in: BMC ophthalmology (2022)

APAC medications have a protective effect against NPDR development. Diabetic patients benefit from single use of aspirin or dipyridamole on prevention of NPDR.

Keyphrases

antiplatelet therapy
diabetic retinopathy
acute coronary syndrome
percutaneous coronary intervention
optical coherence tomography
low dose
venous thromboembolism
atrial fibrillation
cardiovascular events
type diabetes
cardiovascular disease
coronary artery disease